Replies to post #246918 on NorthWest Biotherapeutics Inc (NWBO)

[ADVFN_doclee]

In the company's description of itself, it states that it is:

a clinical-stage biotechnology company focused on the discovery, development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins.

So the answer to your question is "No, it is not DCVax technology".